Results 101 to 110 of about 17,800 (195)

Rapid Construction and Characterization of Infectious cDNA Clones and Reporter Viruses of Enteroviruses, Including Enterovirus A71 and Coxsackievirus B5, with Systematic Identification of Critical Determinants for Successful Reporter Virus Generation. [PDF]

Viruses
Zheng H, Zhao T, Fu M, Niu Z, Xing Y, Cai X, Long JE.   +6 more
europepmc   +1 more source

Post-EV71 vaccination outcomes in meningoencephalitis: no increased clinical severity compared with other enterovirus subtypes in a single-center retrospective study. [PDF]

Front Cell Infect Microbiol
Luo Y, Guo Y, Liao X, Zhu Y, Wang Y.
europepmc   +1 more source

Beyond Pandemic Preparedness: Reframing Protracted War Against Infectious Diseases. [PDF]

Viruses
Zheng M.
europepmc   +1 more source

Detection rate, clinical characteristics, and molecular characterization of enterovirus and parechovirus infections in Thai infants during the first three months of life. [PDF]

Virol J
Phattraprayoon N, Paramagul P, Chirachanchai O, Siriporn T, Srisomboon W, Puenpa J, Poovorawan Y, Wanlapakorn N.   +7 more
europepmc   +1 more source

Comparative analysis of deep mutational scanning datasets in enteroviruses A and B identifies functional divergence and therapeutic targets. [PDF]

Nat Ecol Evol
Álvarez-Rodríguez B, Bakhache W, McCormick L, Geller R, Dolan PT.   +4 more
europepmc   +1 more source

Antigenic characterization and mapping of a conserved neutralizing epitope on VP1 of coxsackievirus A5. [PDF]

Front Immunol
Wang C, Jin WP, Wu J, Guo J, Qian SS, Chen XQ, Shen S.   +6 more
europepmc   +1 more source

The enteroviruses.

American practitioner and digest of treatment, 1998
  +7 more sources

Combination of vemurafenib, pleconaril, and AG7404 attenuates enterovirus replication <i>in vitro</i> and <i>in vivo</i>. [PDF]

NAR Mol Med
Ravlo E, Ianevski A, Wolska W, Schjølberg JO, Cámara-Quílez M, Nordli IEO, Sæther IB, Lysvand H, Oksenych V, Vähä-Koskela M, Vainionpää S, Seppänen H, Smura T, Vauhkonen H, Odai R, Stoyanova A, Galabov SA, Galabov AS, Plevka P, Nekoua MP, Hober D, Bjørås M, Kainov DE.   +22 more
europepmc   +1 more source

Epidemiological characteristics and influential factors of hand, foot, and mouth disease reinfection in Southwest China, 2009-2022. [PDF]

BMC Infect Dis
Fu L, Li T, Long J, Xia Y, Li Z, Yang S, Zhao Y, Qi L.   +7 more
europepmc   +1 more source

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity. [PDF]

J Biomed Sci
Soppela S, Kyröläinen HM, Levanova A, Nekoua MP, González-Rodríguez M, Lehto H, Ahmad KLL, Guryanov S, Hytönen VP, Laitinen OH, Junttila IS, Hober D, Butcher SJ, Hankaniemi MM.   +13 more
europepmc   +1 more source